SCHEMBL26100141

SCHEMBL26100141

O=C(Cc1ccc(NCc2ccc(F)cc2)cc1)N1CC[C@@H](CO)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.51
ALDH1A1 P00352 1/20 0.51
KDM4E B2RXH2 2/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
ALOX15 P16050 1/20 0.48
ALOX12 P18054 1/20 0.48
GFER P55789 1/20 0.48
TACR3 P29371 1/20 0.48
MLNR O43193 2/20 0.47
CYP3A4 P08684 2/20 0.47
HSD11B1 P28845 1/20 0.47
PKM P14618 1/20 0.44
POLB P06746 2/20 0.44
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
EPHX2 P34913 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP19A1 P11511 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26101890 1.00 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL23747566 0.87 NAMPT (0.52) SMN1; SMN2ALDH1A1TACR3MLNRCYP3A4
SCHEMBL23747807 0.87 NAMPT (0.52) SMN1; SMN2ALDH1A1TACR3MLNRCYP3A4
SCHEMBL26101112 0.81 MLNR (0.48) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL26101852 0.81 GAA (0.51) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL26097985 0.80 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL26100870 0.79 HSD11B1 (0.51) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL26100459 0.79 HSD11B1 (0.51) SMN1; SMN2ALDH1A1KDM4EGAAMAPT
SCHEMBL26102249 0.76 ALDH1A1 (0.57) SMN1; SMN2ALDH1A1GAAMAPTGFER
SCHEMBL23747788 0.74 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1KDM4EGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230133132-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230133132-A1 NAMPT MODULATORS NAMPT, MC4R, SIRT1 SMN1; SMN2 1161/4885ALDH1A1 2019/4885KDM4E 2721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.